Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes

There is compelling evidence suggesting that the immune‐modulating effects of many conventional chemotherapeutics, including platinum‐based agents, play a crucial role in achieving clinical response. One way in which chemotherapeutics can engage a tumor‐specific immune response is by triggering an immunogenic mode of tumor cell death (ICD), which then acts as an “anticancer vaccine”. In spite of being a mainstay of chemotherapy, there has not been a systematic attempt to screen both existing and upcoming Pt agents for their ICD ability. A library of chemotherapeutically active Pt agents was evaluated in an in vitro phagocytosis assay, and no correlation between cytotoxicity and phagocytosis was observed. A Pt^II N‐heterocyclic carbene complex was found to display the characteristic hallmarks of a type II ICD inducer, namely focused oxidative endoplasmic reticulum (ER) stress, calreticulin exposure, and both HMGB1 and ATP release, and thus identified as the first small‐molecule immuno‐chemotherapeutic agent.     

The immune-stimulating peptide WKYMVm has therapeutic effects against ulcerative colitis

In this study, we examined the therapeutic effects of an immune-stimulating peptide, WKYMVm, in ulcerative colitis. The administration of WKYMVm to dextran sodium sulfate (DSS)-treated mice reversed decreases in body weight, bleeding score and stool score in addition to reversing DSS-induced mucosa destruction and shortened colon. The WKYMVm-induced therapeutic effect against ulcerative colitis was strongly inhibited by a formyl peptide receptor (FPR) 2 antagonist, WRWWWW, indicating the crucial role of FPR2 in this effect. Mechanistically, WKYMVm effectively decreases intestinal permeability by stimulating colon epithelial cell proliferation. WKYMVm also strongly decreases interleukin-23 and transforming growth factor-β production in the colon of DSS-treated mice. We suggest that the potent immune-modulating peptide WKYMVm and its receptor FPR2 may be useful in the development of efficient therapeutic agents against chronic intestinal inflammatory diseases.     

Advanced Catalytic Performance of Au–Pt Double‐Walled Nanotubes and Their Fabrication through Galvanic Replacement Reaction

Bimetallic tubular nanostructures have been the focus of intensive research as they have very interesting potential applications in various fields including catalysis and electronics. In this paper, we demonstrate a facile method for the fabrication of Au–Pt double‐walled nanotubes (Au–Pt DWNTs). The DWNTs are fabricated through the galvanic displacement reaction between Ag nanowires and various metal ions, and the Au–Pt DWNT catalysts exhibit high active catalytic performances toward both methanol electro‐oxidation and 4‐nitrophenol (4‐NP) reduction. First, they have a high electrochemically active surface area of 61.66 m² g^?1, which is close to the value of commercial Pt/C catalysts (64.76 m² g^?1), and the peak current density of Au–Pt DWNTs in methanol oxidation is recorded as 138.25 mA mg^?1, whereas those of Pt nanotubes, Au/Pt nanotubes (simple mixture), and commercial Pt/C are 24.12, 40.95, and120.65 mA mg^?1, respectively. The Au–Pt DWNTs show a markedly enhanced electrocatalytic activity for methanol oxidation compared with the other three catalysts. They also show an excellent catalytic performance in comparison with common Au nanotubes for 4‐nitrophenol (4‐NP) reduction. The attractive performance exhibited by these prepared Au–Pt DWNTs can be attributed to their unique structures, which make them promising candidates as high‐performance catalysts.     

Identification of novel peptides that stimulate human neutrophils

Neutrophils play a key role in innate immunity, and the identification of new stimuli that stimulate neutrophil activity is a very important issue. In this study, we identified three novel peptides by screening a synthetic hexapeptide combinatorial library. The identified peptides GMMWAI, MMHWAM, and MMHWFM caused an increase in intracellular Ca2+ in a concentration-dependent manner via phospholipase C activity in human neutrophils. The three peptides acted specifically on neutrophils and monocytes and not on other non-leukocytic cells. As a physiological characteristic of the peptides, we observed that the three peptides induced chemotactic migration of neutrophils as well as stimulated superoxide anion production. Studying receptor specificity, we observed that two of the peptides (GMMWAI and MMHWFM) acted on formyl peptide receptor (FPR)1 while the other peptide (MMHWAM) acted on FPR2. Since the three novel peptides were specific agonists for FPR1 or FPR2, they might be useful tools to study FPR1- or FPR2-mediated immune response and signaling.     

A Genetically Encoded,Phage‐Displayed Cyclic‐Peptide Library

Superior to linear peptides in biological activities, cyclic peptides are considered to have great potential as therapeutic agents. To identify cyclic‐peptide ligands for therapeutic targets, phage‐displayed peptide libraries in which cyclization is achieved by the covalent conjugation of cysteines have been widely used. To resolve drawbacks related to cysteine conjugation, we have invented a phage‐display technique in which its displayed peptides are cyclized through a proximity‐driven Michael addition reaction between a cysteine and an amber‐codon‐encoded N^?‐acryloyl‐lysine (AcrK). Using a randomized 6‐mer library in which peptides were cyclized at two ends through a cysteine–AcrK linker, we demonstrated the successful selection of potent ligands for TEV protease and HDAC8. All selected cyclic peptide ligands showed 4‐ to 6‐fold stronger affinity to their protein targets than their linear counterparts. We believe this approach will find broad applications in drug discovery.     

A Genetically Encoded,Phage‐Displayed Cyclic‐Peptide Library

Superior to linear peptides in biological activities, cyclic peptides are considered to have great potential as therapeutic agents. To identify cyclic‐peptide ligands for therapeutic targets, phage‐displayed peptide libraries in which cyclization is achieved by the covalent conjugation of cysteines have been widely used. To resolve drawbacks related to cysteine conjugation, we have invented a phage‐display technique in which its displayed peptides are cyclized through a proximity‐driven Michael addition reaction between a cysteine and an amber‐codon‐encoded N^?‐acryloyl‐lysine (AcrK). Using a randomized 6‐mer library in which peptides were cyclized at two ends through a cysteine–AcrK linker, we demonstrated the successful selection of potent ligands for TEV protease and HDAC8. All selected cyclic peptide ligands showed 4‐ to 6‐fold stronger affinity to their protein targets than their linear counterparts. We believe this approach will find broad applications in drug discovery.     

Trp-Lys-Tyr-Met-Val-Met stimulates phagocytosis via phospho-lipase D-dependent signaling in mouse dendritic cells

Dendritic cells (DCs) play a key role in activating the immune response against invading pathogens as well as dying cells or tumors. Although the immune response can be initiated by the phagocytic activity by DCs, the molecular mechanism involved in this process has not been fully investigated. Trp-Lys-Tyr-Met-Val-Met-NH(2) (WKYMVM) stimulates the activation of phospholipase D (PLD) via Ca(2+) increase and protein kinase C activation in mouse DC cell line, DC2.4. WKYMVM stimulates the phagocytic activity, which is inhibited in the presence of N-butanol but not t-butanol in DC2.4 cells. Furthermore, the addition of phosphatidic acid, an enzymatic product of PLD activity, enhanced the phagocytic activity in DC2.4 cells. Since at least two of formyl peptide receptor (FPR) family (FPR1 and FPR2) are expressed in DC2.4 as well as in mouse bone marrow-derived dendritic cells, this study suggests that the activation of FPR family by WKYMVM stimulates the PLD activity resulting in phagocytic activity in DC2.4 cells.     

Clickable functionalization of liposomes with the gH625 peptide from Herpes simplex virus type I for intracellular drug delivery

Liposomes externally modified with the nineteen residues gH625 peptide, previously identified as a membrane‐perturbing domain in the gH glycoprotein of Herpes simplex virus type I, have been prepared in order to improve the intracellular uptake of an encapsulated drug. An easy and versatile synthetic strategy, based on click chemistry, has been used to bind, in a controlled way, several copies of the hydrophobic gH625 peptide on the external surface of 1,2‐dioleoyl‐sn‐glycero‐3‐phosphocholine (DOPG)‐based liposomes. Electron paramagnetic resonance studies, on liposomes derivatized with gH625 peptides, which are modified with the 2,2,6,6‐tetramethylpiperidine‐1‐oxyl‐4‐amino‐4‐carboxylic acid (TOAC) spin label in several peptide positions, confirm the positioning of the coupled peptides on the liposome external surface, whereas dynamic light scattering measurements indicate an increase of the diameter of the liposomes of approximately 30 % after peptide introduction. Liposomes have been loaded with the cytotoxic drug doxorubicin and their ability to penetrate inside cells has been evaluated by confocal microscopy experiments. Results suggest that liposomes functionalized with gH625 may act as promising intracellular targeting carriers for efficient delivery of drugs, such as chemotherapeutic agents, into tumor cells.     

Versatile Nanodelivery Platform to Maximize siRNA Combination Therapy

The unsatisfactory outcomes of typical multiple cytotoxic chemotherapeutic combination therapies used to treat patients have fostered a need for new unconventional combinations of therapeutic agents. Among the candidates, siRNA has been widely discussed and tested. However, the right time right place codelivery of siRNA with other types of active ingredients is challenging because of the possible differences among their physiochemical and pharmacodynamics properties. To accomplish a synergistic cytotoxic effect, a nanoassembly is thus designed to codeliver siRNA with other therapeutic agents. A siRNA, targeting prosurvival gene for the p75 neurotrophin receptor, and an organelle‐fusing peptide, targeting mitochondria, are layered onto a nanotemplate by charge–charge interaction, followed by a layer of CD44 targeting ligand. The formulated triple‐functional nanomedicine is efficiently internalized by the CD44 expressing triple‐negative breast cancer cells. The encapsulated siRNA and the pro‐apoptotic peptide are released inside cells, silencing the intended prosurvival gene, and inducing apoptosis by fusing the mitochondrial membrane, respectively. A synergistic effect is achieved by this three‐agent combination. The design of the developed multifunctional nanomedicine can be generalized to deliver other siRNA and drugs for a maximum therapeutic combination with minimal off‐targeting effects.

     

An Effective Approach to Obtain Near‐Infrared Emission from Binuclear Platinum(II) Complexes Involving Thiophenpyridine‐Isoquinoline Bridging Ligand in Solution‐Processed OLEDs

Bimetallic complexes have become an emerging hot topic in field of luminous applications in recent years. Unlike the traditional modification on a cyclometalated ligand, grafting an additional metal ion provides a novel approach to tune molecular conjugation as well as the spin orbital coupling (SOC). Herein, we demonstrate a new kind of binuclear platinum(II) complex Pt‐3 that possesses an asymmetric thiophenpyridine‐isoquinoline bridging ligand. Compared to its mononuclear analogues of Pt‐1 and Pt‐2, an extremely large redshift emission from 576 and 618 nm to 721 nm was observed in solution. Binding of two metal ions helps to enhance molecular planarity, extend conjugation and suppress excited state distortion. However, their quantum yields tend to remarkably decrease with increasing red‐shift emission as following the “energy gap law”. The relatively larger HOMO/LUMO separation that induced by the second platinum ion also decreases the oscillator strength at the lowest singlet state, and goes against the fast radiative decay process. Solution‐processed organic light‐emitting diodes (OLEDs) based on Pt‐1, Pt‐2 and Pt‐3 achieved external quantum efficiencies (EQEs) and luminance/radiant emittance of 13.6% and 13640 cd/m², 3.5% and 3754 cd/m², 0.9% and 7981 mW/Sr/m² with the corresponding electroluminescent (EL) emission peaked at 580 nm, 625 nm and 708 nm, respectively. This work emphasizes the complement argument of the commonly largely reported symmetric binuclear configurations, and provides a new view to photophysical mechanism and design strategies for bimetallic species.     

A Novel d‐Peptide Identified by Mirror‐Image Phage Display Blocks TIGIT/PVR for Cancer Immunotherapy

The low response rate and adaptive resistance of PD‐1/PD‐L1 blockade demands the studies on novel therapeutic targets for cancer immunotherapy. We discovered that a novel immune checkpoint TIGIT expressed higher than PD‐1 in many tumors especially anti‐PD‐1 resistant tumors. Here, mirror‐image phage display bio‐panning was performed using the d ‐enantiomer of TIGIT synthesized by hydrazide‐based native chemical ligation. d ‐peptide ^DTBP‐3 was identified, which could occupy the binding interface and effectively block the interaction of TIGIT with its ligand PVR. ^DTBP‐3 showed proteolytic resistance, tumor tissue penetrating ability, and significant tumor suppressing effects in a CD8⁺ T cell dependent manner. More importantly, ^DTBP‐3 could inhibit tumor growth and metastasis in anti‐PD‐1 resistant tumor model. This is the first d ‐peptide targeting TIGIT, which could serve as a potential candidate for cancer immunotherapy.     

Interaction of PiB‐Derivative Metal Complexes with Beta‐Amyloid Peptides: Selective Recognition of the Aggregated Forms

Metal complexes are increasingly explored as imaging probes in amyloid peptide related pathologies. We report the first detailed study on the mechanism of interaction between a metal complex and both the monomer and the aggregated form of Aβ_1–40 peptide. We have studied lanthanide(III) chelates of two PiB‐derivative ligands (PiB=Pittsburgh compound B), L¹ and L², differing in the length of the spacer between the metal‐complexing DO3A macrocycle (DO3A= 1,4,7,10‐tetraazacyclododecane‐1,4,7‐triacetic acid) and the peptide‐recognition PiB moiety. Surface plasmon resonance (SPR) and saturation transfer difference (STD) NMR spectroscopy revealed that they both bind to aggregated Aβ_1–40 (K_D=67–160 μM ), primarily through the benzothiazole unit. HSQC NMR spectroscopy on the ¹⁵N‐labeled, monomer Aβ_1–40 peptide indicates nonsignificant interaction with monomeric Aβ. Time‐dependent circular dichroism (CD), dynamic light scattering (DLS), and TEM investigations of the secondary structure and of the aggregation of Aβ_1–40 in the presence of increasing amounts of the metal complexes provide coherent data showing that, despite their structural similarity, the two complexes affect Aβ fibril formation distinctly. Whereas GdL¹, at higher concentrations, stabilizes β‐sheets, GdL² prevents aggregation by promoting α‐helical structures. These results give insight into the behavior of amyloid‐targeted metal complexes in general and contribute to a more rational design of metal‐based diagnostic and therapeutic agents for amyloid‐ associated pathologies.     

Pt NPs catalyzed chemiluminescence method for Hg2+ detection based on a flow injection system

Establishing a simple and accurate method for Hg²⁺ detection is of great importance for the environment and human health. In this work, platinum nanoparticles (Pt NPs) with different capped agents and morphologies were synthesized. It was found that Pt NPs exhibited peroxidase‐like activity that can catalyze the chemiluminescence (CL) of the luminol system without H₂O₂. The most intensive CL signals were obtained by using PVP‐capped Pt NPs as catalysis. Based on the fact that Hg²⁺ could further enhance the CL intensity in the Pt NPs‐luminol CL system, a Pt NPs‐catalyzed CL method based on a flow injection system is developed for the sensitive analysis of Hg²⁺. When the concentration of Hg²⁺ in the system increases, the CL intensity would together increase, thereby achieving sensitive Hg²⁺ detection. The limit of detection (LOD) was calculated to be 8.6 nM. This developed method provides a simple and rapid approach for the sensitive detection of Hg²⁺ and shows great promise for applications in other complex systems.     

Improving peptide identification using an empirical peptide retention time database

Peptide retention time (RT) is independent of tandem mass spectrometry (MS/MS) parameters and can be combined with MS/MS information to enhance peptide identification. In this paper, we utilized peptide empirical RT and MS/MS for peptide identification. This new approach resulted in the construction of an Empirical Peptide Retention Time Database (EPRTD) based on peptides showing a false‐positive rate (FPR) ≤1%, detected in several liquid chromatography (LC)/MS/MS analyses. In subsequent experiments, the RT of peptides with FPR >1% was compared with empirical data derived from the EPRTD. If the experimental RT was within a specified time range of the empirical value, the corresponding MS/MS spectra were accepted as positive. Application of the EPRTD approach to simple samples (known protein mixtures) and complex samples (human urinary proteome) revealed that this method could significantly enhance peptide identification without compromising the associated confidence levels. Further analysis indicated that the EPRTD approach could improve low‐abundance peptides and with the expansion of the EPRTD the number of peptide identifications will be increased. This approach is suitable for large‐scale clinical proteomics research, in which tens of LC/MS/MS analyses are run for different samples with similar components. Copyright © 2008 John Wiley & Sons, Ltd.     

The Comparability of Pt to Pt‐Ru in Catalyzing the Hydrogen Oxidation Reaction for Alkaline Polymer Electrolyte Fuel Cells Operated at 80 °C

The Pt‐catalyzed hydrogen oxidation reaction (HOR) for alkaline polymer electrolyte fuel cells (APEFCs) has been one of the focus subjects in current fuel‐cell research. The Pt catalyst is inferior for HOR in alkaline solutions, and alloying with Ru is an effective promotion strategy. APEFCs with Pt‐Ru anodes have provided a performance benchmark over 1 W cm^?2 at 60 °C. The Pt anode is now found to be in fact as good as the Pt‐Ru anode for APEFCs operated at elevated conditions. At 80 °C with appropriate gas back‐pressure, the cell with a Pt anode exhibits a peak power density of about 1.9 W cm^?2, which is very close to that with a Pt‐Ru anode. Even by decreasing the anode Pt loading to 0.1 mg cm^?2, over 1.5 W cm^?2 can still be achieved at 80 °C. This finding alters the previous understanding about the Pt catalyzed HOR in alkaline media and casts a new light on the development of practical and high‐power APFEC technology.     

Facile Synthesis of Platinum–Cerium(IV) Oxide Hybrids Arched on Reduced Graphene Oxide Catalyst in Reverse Micelles with High Activity and Durability for Hydrolysis of Ammonia Borane

Highly dispersed Pt‐CeO₂ hybrids arched on reduced graphene oxide (Pt‐CeO₂/rGO) were facilely synthesized by a combination of the reverse micelle technique and a redox reaction without any additional reductant or surfactant. Under a N₂ atmosphere, the redox reaction between Ce³⁺ and Pt²⁺ occurs automatically in alkaline solution, which results in the formation of Pt‐CeO₂/rGO nanocomposites (NCs). The as‐synthesized Pt‐CeO₂/rGO NCs exhibit superior catalytic performance relative to that shown by the free Pt nanoparticles, Pt/rGO, Pt‐CeO₂ hybrid, and the physical mixture of Pt‐CeO₂ and rGO; furthermore, the nanocomposites show significantly better activity than the commercial Pt/C catalyst toward the hydrolysis of ammonia borane (NH₃BH₃) at room temperature. Moreover, the Pt‐CeO₂/rGO NCs have remarkable stability, and 92 % of their initial catalytic activity is preserved even after 10 runs. The excellent activity of the Pt‐CeO₂/rGO NCs can be attributed not only to the synergistic structure but also to the electronic effects of the Pt‐CeO₂/rGO NCs among Pt, CeO₂, and rGO.     

A Pd/C‐CeO2 Anode Catalyst for High‐Performance Platinum‐Free Anion Exchange Membrane Fuel Cells

One of the biggest obstacles to the dissemination of fuel cells is their cost, a large part of which is due to platinum (Pt) electrocatalysts. Complete removal of Pt is a difficult if not impossible task for proton exchange membrane fuel cells (PEM‐FCs). The anion exchange membrane fuel cell (AEM‐FC) has long been proposed as a solution as non‐Pt metals may be employed. Despite this, few examples of Pt‐free AEM‐FCs have been demonstrated with modest power output. The main obstacle preventing the realization of a high power density Pt‐free AEM‐FC is sluggish hydrogen oxidation (HOR) kinetics of the anode catalyst. Here we describe a Pt‐free AEM‐FC that employs a mixed carbon‐CeO₂ supported palladium (Pd) anode catalyst that exhibits enhanced kinetics for the HOR. AEM‐FC tests run on dry H₂ and pure air show peak power densities of more than 500 mW cm^?2.     

A luminescent bis(pyridyl)‐substituted benzimidazole platinum(II) complex exhibiting an intermolecular anagostic interaction

The photophysical properties of transition metal complexes of the 5,6‐dimethyl‐2‐(pyridin‐2‐yl)‐1‐(pyridin‐2‐ylmethyl)‐1H‐benzimidazole ligand are of interest. Dichlorido[5,6‐dimethyl‐2‐(pyridin‐2‐yl)‐1‐(pyridin‐2‐ylmethyl)‐1H‐benzimidazole‐κ²N ²,N ³]platinum(II), [PtCl₂(C₂₀H₁₈N₄)], is luminescent in the solid state at room temperature. The compound displays a distorted square‐planar coordination geometry. The Pt—N(imidazole) bond length is shorter than the Pt—N(pyridine) bond length. The extended structure reveals that symmetry‐related molecules display weak C—H…N, C—H…Cl, and C—H…Pt hydrogen‐bonding interactions that are clearly discernable in the Hirshfeld surface and fingerprint plots. The intermolecular C—H…Pt and C—H…N interactions have been explored using density functional theory. The result of an analysis of the distance dependence of C—H…Pt yields a value consistent with that observed in the solid‐state structure. The energy of interaction for the C—H…Pt interaction is found to be about −11 kJ mol⁻¹.     

A Methylthio‐Functionalized‐MOF Photocatalyst with High Performance for Visible‐Light‐Driven H2 Evolution

Recently, the emergence of photoactive metal–organic frameworks (MOFs) has given great prospects for their applications as photocatalytic materials in visible‐light‐driven hydrogen evolution. Herein, a highly photoactive visible‐light‐driven material for H₂ evolution was prepared by introducing methylthio terephthalate into a MOF lattice via solvent‐assisted ligand‐exchange method. Accordingly, a first methylthio‐functionalized porous MOF decorated with Pt co‐catalyst for efficient photocatalytic H₂ evolution was achieved, which exhibited a high quantum yield (8.90 %) at 420 nm by use sacrificial triethanolamine. This hybrid material exhibited perfect H₂ production rate as high as 3814.0 μmol g^?1 h^?1, which even is one order of magnitude higher than that of the state‐of‐the‐art Pt/MOF photocatalyst derived from aminoterephthalate.